Previous 10 | Next 10 |
NRx Pharmaceuticals, Inc. (NRXP) Q4 2021 Earnings Conference Call March 31 2022, 08:30 AM ET Company Participants Eric Goldstein - MD, LifeSci Advisors, IR Robert Besthof - Interim CEO, Head of Operations & Chief Commercial Officer Ira Strassberg - CFO and Treasurer Conference Call Partic...
NRx Pharmaceuticals press release (NASDAQ:NRXP): FY GAAP EPS of -$1.98. As of December 31, 2021, cash was $27.6 million, compared to $1.9 million as of December 31, 2020. Shares -4.9% PM. For further details see: NRx Pharmaceuticals GAAP EPS of -$1.98
I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests No Clinical Benefit with Addition of Nebulized ZYESAMI® (aviptadil) When Given by Mouth Inhalation in Critically Ill Patients with COVID-19 PR Newswire SAN FRANCISCO , March 31...
NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results PR Newswire Company to Host Conference Call and Webcast March 31, 2022 , at 8:30am ET RADNOR, Pa. , March 31, 2022 /PRNewswire/ -- NRx Pharmaceu...
NRx Pharmaceuticals to Report Year-End 2021 Results on March 31, 2022 PR Newswire --Company to Host Conference Call March 31, 2022 , at 8:30AM ET --- RADNOR, Pa. , March 28, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP...
NRx Pharmaceuticals (NASDAQ:NRXP) appointed Ira Strassberg as CFO and treasurer, effective March 15. "Ira has been serving NRx effectively in a financial consulting capacity since August, 2021," said Robert Besthof, interim CEO. Strassberg has previously served as Deputy CFO at Cant...
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer PR Newswire RADNOR, Pa. , March 18, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage pharmaceutical company, announced today that the co...
Volt Information Sciences (NYSE:VOLT) +96% on acquisition proposal from ACS Solutions affiliate. Zhongchao (NASDAQ:ZCMD) +41%. Turquoise Hill Resources (NYSE:TRQ) +31% after receiving Rio Tinto's takeover proposal. Amphastar Pharmaceuticals (NASDAQ:AMPH) +24%. Mullen Autom...
NRx Pharmaceuticals (NASDAQ:NRXP) announced that Jonathan Javitt, MD, MPH, has retired as Chief Executive Officer effective immediately. The Board of Directors appointed Robert Besthof, Head of Operations and Chief Commercial Officer, as Interim CEO. Dr. Javitt will continue to be on the boar...
NRx Pharmaceuticals Announces Leadership Transition Robert Besthof, Head of Operations and Chief Commercial Officer, Appointed Interim CEO Jonathan Javitt, MD, MPH, to Serve as a Consultant and Chief Scientist and Remain on the Board of Directors PR Newswire RA...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Website:
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing PR Newswire New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 202...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 PR Newswire RADNOR, Pa. , June 20, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"...
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors PR Newswire Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology ...